Back
~
4
min read
· Posted on
August 4, 2025

ResMed investors sleep soundly, Figma pops 250% on IPO, Ozempic faces a new challenger

What's the key learning?

.

Ready to win at money?

Sign up for Flux and join 100,000 members of the Flux family

A button to App StoreGoogle Play store button
Excellent  4.9 out of 5
Star rating
No items found.